Why is Eli Lilly and Company stock down today?
April 11, 2026
Eli Lilly and Company
LLY · NYQ · USD
vs. prev. close $955.19
Last updated Apr 10, 2026 20:00
Intraday Chart — 5-min intervals
LLY · less than a minute ago
Eli Lilly and Company dips 1.65% — Simply Wall St. reports
Eli Lilly and Company (LLY) is trading lower, at $939. 47 — down 1. 65% from yesterday's close of $955. 19. Today's move appears driven by recent headlines, including "India GLP 1 Generics Test Novo Nordisk Pricing Power And Valuation" and "Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader". News sentiment around LLY is leaning mixed.
The broader market is in risk-on mode (S&P 500: -0. 1%, Nasdaq: +0. 4%, Dow Jones: -0. 6%, Shanghai: +2. 5%, Hang Seng: +0. 5%). Past performance does not guarantee future results.
Key Factors
Auto-generated analysis · Not financial advice
India GLP 1 Generics Test Novo Nordisk Pricing Power And Valuation
Simply Wall St.·about 5 hours agoneutralEli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader
24/7 Wall St.·about 10 hours agoneutralLLY Launches GLP-1 Pill, Expands Access Through Pharmacy Partnerships
Zacks·about 10 hours agoneutralNovo Nordisk's GLP-1 pill momentum faces pricing test, says leading bank
Proactive·about 10 hours agoneutralAmazon Pharmacy to offer Eli Lilly’s Foundayo via same-day delivery
TipRanks·about 13 hours agoneutralEli Lilly loses weight loss drug market share as generics flood India
Quartz·about 13 hours agoneutralLifeMD Now Offers Eli Lilly's Foundayo to Eligible Patients Through its Weight Management Program
MT Newswires·about 13 hours agoneutralWho Benefits From Amazon Pharmacy Stocking Eli Lilly’s New Weight Loss Pill
24/7 Wall St.·about 14 hours agoneutral
S&P 500
-0.11%
Nasdaq
+0.35%
Dow Jones
-0.56%
Shanghai
+2.47%
Hang Seng
+0.55%
Nikkei 225
+1.84%
FTSE 100
-0.03%
Nifty 50
+1.16%
DAX
-0.01%
OMX Stockholm
+0.99%
Search another stock